BLT benitec biopharma limited

For what it is worth, a little bird told me that, at the...

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    For what it is worth, a little bird told me that, at the beginning of November, Calimmune was halfway through dosing its second cohort (2 out of 4 patients) and is on track for cohort three to start dosing early in the New Year. If this is true, then we should be looking at some results Q3 2015.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.